GLUT-1 expression in mesenchymal tumors: an immunohistochemical study of 247 soft tissue and bone neoplasms

Human Pathology

Volumn 39, Issue 10, 2008, Pages 1519-1526

  Ahrens, William A ^a   Ridenour III, Robert V ^a   Caron, Bolette L ^a   Miller, Dylan V ^a   Folpe, Andrew L ^a  

^a MAYO CLINIC   (United States)

Author keywords

GLUT 1; Hemangioma; HIF1 ; Hypoxia; Perineurioma; Sarcoma

Indexed keywords

GLUCOSE TRANSPORTER 1; HYPOXIA INDUCIBLE FACTOR 1ALPHA;

ARTICLE; BONE CANCER; CAPILLARY HEMANGIOMA; CELL PROLIFERATION; CONTROLLED STUDY; DERMATOFIBROSARCOMA PROTUBERANS; DIFFERENTIAL DIAGNOSIS; EPITHELIOID SARCOMA; HEMANGIOMA; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MESENCHYMOMA; MYXOMA; NERVE SHEATH; NEURILEMOMA; NEUROFIBROMA; PROTEIN EXPRESSION; SOFT TISSUE CANCER;

BONE NEOPLASMS; CELL COUNT; GLUCOSE TRANSPORTER TYPE 1; HUMANS; IMMUNOHISTOCHEMISTRY; MESENCHYMOMA; NEOPLASM PROTEINS; SOFT TISSUE NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 50649099452     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humpath.2008.03.002     Document Type: Article

References (26)

1. Mueckler M. Facilitative glucose transporters. Eur J Biochem 219 (1994) 713-725
2. Kasahara M., and Hinkle P.C. Reconstitution and purification of the D-glucose transporter from human erythrocytes. J Biol Chem 252 (1977) 7384-7390
3. Pardridge W.M., Boado R.J., and Farrell C.R. Brain-type glucose transporter (GLUT-1) is selectively localized to the blood-brain barrier. Studies with quantitative western blotting and in situ hybridization. J Biol Chem 265 (1990) 18035-18040
4. Mayer A., Hockel M., and Vaupel P. Endogenous hypoxia markers in locally advanced cancers of the uterine cervix: reality or wishful thinking?. Strahlenther Onkol 182 (2006) 501-510
5. Takata K., Hirano H., and Kasahara M. Transport of glucose across the blood-tissue barriers. Int Rev Cytol 172 (1997) 1-53
6. Harik S.I., Kalaria R.N., Andersson L., et al. Immunocytochemical localization of the erythroid glucose transporter: abundance in tissues with barrier functions. J Neurosci 10 (1990) 3862-3872
7. Younes M., Lechago L.V., Somoano J.R., et al. Wide expression of the human erythrocyte glucose transporter Glut1 in human cancers. Cancer Res 56 (1996) 1164-1167
8. North P.E., Waner M., Mizeracki A., et al. GLUT1: a newly discovered immunohistochemical marker for juvenile hemangiomas. Hum Pathol 31 (2000) 11-22
9. Leon-Villapalos J., Wolfe K., and Kangesu L. GLUT-1: an extra diagnostic tool to differentiate between haemangiomas and vascular malformations. Br J Plast Surg 58 (2005) 348-352
10. Mo J.Q., Dimashkieh H.H., and Bove K.E. GLUT1 endothelial reactivity distinguishes hepatic infantile hemangioma from congenital hepatic vascular malformation with associated capillary proliferation. Hum Pathol 35 (2004) 200-209
11. Hernandez F., Navarro M., Encinas J.L., et al. The role of GLUT1 immunostaining in the diagnosis and classification of liver vascular tumors in children. J Pediatr Surg 40 (2005) 801-804
12. Hirose T., Tani T., Shimada T., et al. Immunohistochemical demonstration of EMA/Glut1-positive perineurial cells and CD34-positive fibroblastic cells in peripheral nerve sheath tumors. Mod Pathol 16 (2003) 293-298
13. Yamaguchi U., Hasegawa T., Hirose T., et al. Sclerosing perineurioma: a clinicopathological study of five cases and diagnostic utility of immunohistochemical staining for GLUT1. Virchows Arch 443 (2003) 159-163
14. Mentzel T., and Kutzner H. Reticular and plexiform perineurioma: clinicopathological and immunohistochemical analysis of two cases and review of perineurial neoplasms of skin and soft tissues. Virchows Arch 447 (2005) 677-682
15. Smith M.E., Awasthi R., O'Shaughnessy S., et al. Evaluation of perineurial differentiation in epithelioid sarcoma. Histopathology 47 (2005) 575-581
16. Lyons L.L., North P.E., Mac-Moune Lai F., et al. Kaposiform hemangioendothelioma: a study of 33 cases emphasizing its pathologic, immunophenotypic, and biologic uniqueness from juvenile hemangioma. Am J Surg Pathol 28 (2004) 559-568
17. Rao U.N., Finkelstein S.D., and Jones M.W. Comparative immunohistochemical and molecular analysis of uterine and extrauterine leiomyosarcomas. Mod Pathol 12 (1999) 1001-1009
18. Smith M.E., Brown J.I., and Fisher C. Epithelioid sarcoma: presence of vascular-endothelial cadherin and lack of epithelial cadherin. Histopathology 33 (1998) 425-431
19. Lin Z., Weinberg J.M., Malhotra R., et al. GLUT-1 reduces hypoxia-induced apoptosis and JNK pathway activation. Am J Physiol Endocrinol Metab 278 (2000) E958-E966
20. Kalir T., Rahaman J., Hagopian G., et al. Immunohistochemical detection of glucose transporter GLUT1 in benign and malignant fallopian tube epithelia, with comparison to ovarian carcinomas. Arch Pathol Lab Med 129 (2005) 651-654
21. Page T., Hodgkinson A.D., Ollerenshaw M., et al. Glucose transporter polymorphisms are associated with clear-cell renal carcinoma. Cancer Genet Cytogenet 163 (2005) 151-155
22. Alo P.L., Visca P., Botti C., et al. Immunohistochemical expression of human erythrocyte glucose transporter and fatty acid synthase in infiltrating breast carcinomas and adjacent typical/atypical hyperplastic or normal breast tissue. Am J Clin Pathol 116 (2001) 129-134
23. Younes M., Brown R.W., Stephenson M., et al. Overexpression of Glut1 and Glut3 in stage I nonsmall cell lung carcinoma is associated with poor survival. Cancer 80 (1997) 1046-1051
24. Urano N., Fujiwara Y., Doki Y., et al. Overexpression of hypoxia-inducible factor-1 alpha in gastric adenocarcinoma. Gastric Cancer 9 (2006) 44-49
25. Younes M., Juarez D., Lechago L.V., et al. Glut 1 expression in transitional cell carcinoma of the urinary bladder is associated with poor patient survival. Anticancer Res 21 (2001) 575-578
26. Burstein D.E., Nagi C., Kohtz D.S., et al. Immunodetection of GLUT1, p63 and phospho-histone H1 in invasive head and neck squamous carcinoma: correlation of immunohistochemical staining patterns with keratinization. Histopathology 48 (2006) 717-722